Accordant’s health programs, including its Gaucher disease program, have received a special Disease Management (DM) Accreditation from the National…
admin
Chris Comish serves as the Publisher of the website, and is responsible for directing the editorial focus as well as putting the finishing touches on many featured articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by admin
Gaucher disease type 1 (GD1) patients who continued Cerdelga (eliglustat) treatment in an extension study confirmed general organ improvement. The…
National Institutes of Health researchers found a molecule that might one day be used as a treatment for Gaucher and…
According to a recent case study and literature review from Yale University School of Medicine, people with Gaucher disease (GD)…
A new study from Japan shows promise for enzyme replacement therapy with velaglucerase alfa as a treatment for Gaucher disease. The…
An initial study from Japan demonstrated that oral ambroxol may help treat forms of Gaucher disease characterized by neurological symptoms. The study, …
A study by an international group of researchers in Israel, the U.S., and Germany indicates that type I interferon may contribute to Gaucher…
Scientists in the Netherlands have made a discovery that may advance the treatment of the genetic disorder known as Pompe disease.